Noticias de PCVX_US
Noticias del mercado
Últimas noticias sobre PCVX_US — 247 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Ticker: PCVX_US ✕
247 resultados
Latham Advises on Vaxcyte Concurrent Public Offerings of Common Stock Pre Funded Warrants
Firm represents the underwriters in the offerings by the clinical-stage vaccine innovation company.
Vaxcyte prices US$1B in stock, warrants and convertible notes
Vaxcyte priced US$500M in stock and pre-funded warrants alongside US$500M in 1.5 per cent notes, with an Oct. 9 close expected.
Las acciones de Vaxcyte informan el éxito de OPUS-1 después de una caída del 9,65 por ciento
Vaxcyte stock traded at USD 66.70 on October 6, 2026, while VAX-31 met 20 of 20 PCV20 comparisons. A
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of concurrent...
Markets & Stocks
Stock quotes, market indicators and the latest market news.
Página 4 de 13